Tailor Bio is a pioneering startup operating in the healthcare sector, specifically in the field of precision medicine for cancer treatment. The company's primary focus is on chromosomal instability (CIN), a genomic phenomenon found in 80% of all cancers. CIN is often associated with more aggressive and harder to treat forms of cancer.

Tailor Bio's business model revolves around the development of a pan-cancer precision medicine platform. This platform leverages the company's unique understanding of CIN to identify new therapeutic targets. In simpler terms, they are using their knowledge of how cancer cells change and mutate to find new ways to treat cancer.

The company's platform also aims to improve patient stratification. This means they are working on ways to categorize patients based on their specific type of cancer and how it's likely to progress. This could lead to more targeted and effective treatments, as doctors would have a better understanding of which treatments would work best for each patient.

Tailor Bio's clients are primarily healthcare providers and research institutions. They operate in the global healthcare market, with a specific focus on oncology. The company generates revenue by licensing its platform and its findings to healthcare providers and pharmaceutical companies.

In conclusion, Tailor Bio is a promising startup in the healthcare sector, leveraging its unique understanding of CIN to develop more effective cancer treatments.

Keywords: Tailor Bio, Precision Medicine, Chromosomal Instability (CIN), Cancer Treatment, Pan-Cancer Platform, Therapeutic Targets, Patient Stratification, Healthcare Providers, Oncology, Genomic Phenomenon.